Bj xf8 rnestad S, Solbakken M, Jakobsen K, Jentoft S, Bakke O, Progida C. Atlantic cod (Gadus morhua) MHC I localizes to endolysosomal compartments independently of cytosolic sorting signals. Front Cell Dev Biol. 2023;11:1050323 pubmed publisher

Joung J, Kirchgatterer P, Singh A, Cho J, Nety S, Larson R, et al. CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity. Nat Commun. 2022;13:1606 pubmed publisher

Filali L, Puissegur M, Cortacero K, Cussat Blanc S, Khazen R, Van Acker N, et al. Ultrarapid lytic granule release from CTLs activates Ca2+-dependent synaptic resistance pathways in melanoma cells. Sci Adv. 2022;8:eabk3234 pubmed publisher

Wang Y, Wang X, Cui X, Zhuo Y, Li H, Ha C, et al. Oncoprotein SND1 hijacks nascent MHC-I heavy chain to ER-associated degradation, leading to impaired CD8+ T cell response in tumor. Sci Adv. 2020;6:eaba5412 pubmed publisher

Yamamoto K, Venida A, Yano J, Biancur D, Kakiuchi M, Gupta S, et al. Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I. Nature. 2020;581:100-105 pubmed publisher

Mensali N, Dillard P, Hebeisen M, Lorenz S, Theodossiou T, Myhre M, et al. NK cells specifically TCR-dressed to kill cancer cells. EBioMedicine. 2019;40:106-117 pubmed publisher

Walseng E, Köksal H, Sektioglu I, Fane A, Skorstad G, Kvalheim G, et al. A TCR-based Chimeric Antigen Receptor. Sci Rep. 2017;7:10713 pubmed publisher

Walchli S, Kumari S, Fallang L, Sand K, Yang W, Landsverk O, et al. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation. Eur J Immunol. 2014;44:774-84 pubmed publisher